Submitted via IRC for SoyCow1984
Drug companies are sitting on generics—43% of recently approved aren't for sale
Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
(Score: 0) by Anonymous Coward on Sunday February 10 2019, @10:06PM
Measles vaccine success is based on correlation = causation though.
They never did an RCT, and at the same time as introducing the vaccine they also introduced blood tests (which are much more specific than clinical symptoms only) and a public health campaign to convince people to stop spreading measles on purpose (which a was a practice meant to ensure you got measles as a child rather than adult).